kc growth medium (lonza) Search Results


90
EuroClone endothelial cell growth medium egm-2 bullet kit
Endothelial Cell Growth Medium Egm 2 Bullet Kit, supplied by EuroClone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pmc11105169-58-6-12?v=EuroClone
Average 90 stars, based on 1 article reviews
endothelial cell growth medium egm-2 bullet kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Promega realtime-glo mt cell viability assay
Realtime Glo Mt Cell Viability Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/10__1016_slash_j__isci__2024__111425-230-51-57?v=Promega
Average 90 stars, based on 1 article reviews
realtime-glo mt cell viability assay - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc glycostem basal growth medium (gbgm)
Glycostem Basal Growth Medium (Gbgm), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/us09464274-325-5-23?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
glycostem basal growth medium (gbgm) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
ATCC mammary epithelial cell growth
Mammary Epithelial Cell Growth, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pm37459799-53-23-35?v=ATCC
Average 99 stars, based on 1 article reviews
mammary epithelial cell growth - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

97
ATCC fibroblast growth basal medium
Fibroblast Growth Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pm36986835-80-49-35?v=ATCC
Average 97 stars, based on 1 article reviews
fibroblast growth basal medium - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

94
Cell Applications Inc human placenta microvascular endothelial cells hpmvecs
A . In BeWo cells, HAND1 mRNA expression was reduced by 61% compared to Allstar negative control treatment after 96 h. D . In <t>HPMVECs,</t> HAND1 mRNA expression was reduced by 69% compared to Allstar negative control treatment after 96 h. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 to 9 passages
Human Placenta Microvascular Endothelial Cells Hpmvecs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/bio_rxiv__2022__11__01__514704-36-0-15?v=Cell+Applications+Inc
Average 94 stars, based on 1 article reviews
human placenta microvascular endothelial cells hpmvecs - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
TCS Cellworks angiokit optimised growth medium pack
A . In BeWo cells, HAND1 mRNA expression was reduced by 61% compared to Allstar negative control treatment after 96 h. D . In <t>HPMVECs,</t> HAND1 mRNA expression was reduced by 69% compared to Allstar negative control treatment after 96 h. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 to 9 passages
Angiokit Optimised Growth Medium Pack, supplied by TCS Cellworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pm21297103-16-37-42?v=TCS+Cellworks
Average 90 stars, based on 1 article reviews
angiokit optimised growth medium pack - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Cell Applications Inc cnob basal medium
Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial <t>adenocarcinoma</t> <t>(MCF-7)</t> and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast <t>(Cnob)</t> cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.
Cnob Basal Medium, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pmc10807943-112-21-28?v=Cell+Applications+Inc
Average 96 stars, based on 1 article reviews
cnob basal medium - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

99
ATCC rpmi growth medium
Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial <t>adenocarcinoma</t> <t>(MCF-7)</t> and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast <t>(Cnob)</t> cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.
Rpmi Growth Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pmc09099757-155-26-22?v=ATCC
Average 99 stars, based on 1 article reviews
rpmi growth medium - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
Angio-Proteomie endothelial cell growth medium bulletkit 2
Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial <t>adenocarcinoma</t> <t>(MCF-7)</t> and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast <t>(Cnob)</t> cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.
Endothelial Cell Growth Medium Bulletkit 2, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pmc04812755-219-28-16?v=Angio-Proteomie
Average 90 stars, based on 1 article reviews
endothelial cell growth medium bulletkit 2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
ATCC growth medium
Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial <t>adenocarcinoma</t> <t>(MCF-7)</t> and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast <t>(Cnob)</t> cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.
Growth Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/pmc04365602-60-0-11?v=ATCC
Average 99 stars, based on 1 article reviews
growth medium - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

95
Angio-Proteomie endothelial growth medium ecs
The process of fabricating engineered tissue. a-i) Tubular PCL scaffolds were fabricated via electrospinning and a-ii) machined to create macropores to enable angiogenesis. a-iii) The presence of the pores was confirmed through visual inspection and SEM imaging (scale bar: 100 µm). b-i and ii) A GelMA hydrogel layer (with or without SMCs) was cast and cured around the electrospun scaffold, and b-iii and iv) the luminal surface was seeded with <t>endothelial</t> cells to enable the formation of an endothelium and sprouting angiogenesis. b-v) Photograph of a TEGV with macropores. c) Creating a large, vascularized tissue by using two vascular grafts is also possible by c-i) casting a GelMA mixture around two electrospun tubes, c-ii) cross-linking the GelMA layer, and c-iii) Seeding ECs in the lumens of the PCL tubes. c-iv) This has the potential to generate large, vascularized tissues. c-v) Photograph of a large construct incorporating two TEVGs.
Endothelial Growth Medium Ecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kc+growth+medium+%28lonza%29/bio_rxiv__2024__04__29__591796-173-23-27?v=Angio-Proteomie
Average 95 stars, based on 1 article reviews
endothelial growth medium ecs - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


A . In BeWo cells, HAND1 mRNA expression was reduced by 61% compared to Allstar negative control treatment after 96 h. D . In HPMVECs, HAND1 mRNA expression was reduced by 69% compared to Allstar negative control treatment after 96 h. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 to 9 passages

Journal: bioRxiv

Article Title: HAND1 knockdown disrupts trophoblast global gene expression

doi: 10.1101/2022.11.01.514704

Figure Lengend Snippet: A . In BeWo cells, HAND1 mRNA expression was reduced by 61% compared to Allstar negative control treatment after 96 h. D . In HPMVECs, HAND1 mRNA expression was reduced by 69% compared to Allstar negative control treatment after 96 h. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 to 9 passages

Article Snippet: Human Placenta Microvascular Endothelial Cells (HPMVECs) were cultured in T75 flasks pre-treated with attachment factor (Cell Applications Inc.) at 37°C, 5% CO 2 in EGM-2 media (Lonza, Allendale, NJ).

Techniques: Expressing, Negative Control, MANN-WHITNEY

A . mRNA expression of GADD45G was shown to be reduced in HAND1 siRNA treated Human Placenta Microvascular Endothelial cells (HPMVECs) when compared to Allstar negative control treated cells. B . Expression of NPPB was increased in in HAND1 siRNA treated HPMVECs when compared to Allstar negative control treated cells. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 passages

Journal: bioRxiv

Article Title: HAND1 knockdown disrupts trophoblast global gene expression

doi: 10.1101/2022.11.01.514704

Figure Lengend Snippet: A . mRNA expression of GADD45G was shown to be reduced in HAND1 siRNA treated Human Placenta Microvascular Endothelial cells (HPMVECs) when compared to Allstar negative control treated cells. B . Expression of NPPB was increased in in HAND1 siRNA treated HPMVECs when compared to Allstar negative control treated cells. Data are median ± interquartile range. Statistical significance was determined using Mann-Whitney test. n = 3 passages

Article Snippet: Human Placenta Microvascular Endothelial Cells (HPMVECs) were cultured in T75 flasks pre-treated with attachment factor (Cell Applications Inc.) at 37°C, 5% CO 2 in EGM-2 media (Lonza, Allendale, NJ).

Techniques: Expressing, Negative Control, MANN-WHITNEY

Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial adenocarcinoma (MCF-7) and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast (Cnob) cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: Synergistic Cytotoxicity of Extracts of Chaga Mushroom and Microalgae against Mammalian Cancer Cells In Vitro

doi: 10.1155/2024/7944378

Figure Lengend Snippet: Effect of supercritical I. obliquus extracts on cancer and normal mammalian cells. Cancer cell and nonmalignant normal cell lines were treated with various doses of two supercritical extracts (see ) of I. obliquus , and cell viability was determined after 24 hr. (a) Comparison between human breast epithelial adenocarcinoma (MCF-7) and human breast epithelial cell (MCF-10A) cells. (b) Comparison between human osteosarcoma (HOS) and canine osteoplast (Cnob) cells. (c) Comparison between canine osteosarcoma (D-17) and Cnob cells. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.

Article Snippet: DH-82, HOS, and D-17 cells were cultured in EMEM (Sigma–Aldrich, Oakville, ON, Canada), MCF-7 and HepG2 in DMEM (Gibco), CnOb in CnOb basal medium supplemented with growth medium (cell applications), MCF-10A cultured in basal medium supplemented with growth medium, and THLE-3 in BEGM with supplements (Lonza Bioscience, Burlington, ON, Canada), as recommended.

Techniques: Comparison

The process of fabricating engineered tissue. a-i) Tubular PCL scaffolds were fabricated via electrospinning and a-ii) machined to create macropores to enable angiogenesis. a-iii) The presence of the pores was confirmed through visual inspection and SEM imaging (scale bar: 100 µm). b-i and ii) A GelMA hydrogel layer (with or without SMCs) was cast and cured around the electrospun scaffold, and b-iii and iv) the luminal surface was seeded with endothelial cells to enable the formation of an endothelium and sprouting angiogenesis. b-v) Photograph of a TEGV with macropores. c) Creating a large, vascularized tissue by using two vascular grafts is also possible by c-i) casting a GelMA mixture around two electrospun tubes, c-ii) cross-linking the GelMA layer, and c-iii) Seeding ECs in the lumens of the PCL tubes. c-iv) This has the potential to generate large, vascularized tissues. c-v) Photograph of a large construct incorporating two TEVGs.

Journal: bioRxiv

Article Title: Hierarchically Vascularized and Implantable Tissue Constructs created through Angiogenesis from Tissue-Engineered Vascular Grafts

doi: 10.1101/2024.04.29.591796

Figure Lengend Snippet: The process of fabricating engineered tissue. a-i) Tubular PCL scaffolds were fabricated via electrospinning and a-ii) machined to create macropores to enable angiogenesis. a-iii) The presence of the pores was confirmed through visual inspection and SEM imaging (scale bar: 100 µm). b-i and ii) A GelMA hydrogel layer (with or without SMCs) was cast and cured around the electrospun scaffold, and b-iii and iv) the luminal surface was seeded with endothelial cells to enable the formation of an endothelium and sprouting angiogenesis. b-v) Photograph of a TEGV with macropores. c) Creating a large, vascularized tissue by using two vascular grafts is also possible by c-i) casting a GelMA mixture around two electrospun tubes, c-ii) cross-linking the GelMA layer, and c-iii) Seeding ECs in the lumens of the PCL tubes. c-iv) This has the potential to generate large, vascularized tissues. c-v) Photograph of a large construct incorporating two TEVGs.

Article Snippet: Human umbilical vein ECs (Lonza, USA) and GFP expressing human umbilical vein ECs (Angio-Proteomie, USA) were cultured in EGM-2 medium (Lonza, USA) and endothelial growth medium ECs (Angio-Proteomie, USA), respectively, with 1% v/v antibiotic-antimycotic solution (Gibco, USA).

Techniques: Imaging, Construct

Endothelialization of the vascular grafts. a) A confocal image showing circumferential coverage of ECs on the lumen surface of the vascular graft after 7 days of culture, red: actin filaments stain (ActinRed™ 555), blue: nuclei stain (DAPI). b) Confocal images of ECs on the surface of the graft lumen at different time points showing the increase of endothelial coverage and proximity of the cells; scale bar = 50 μm. c) Quantitative analysis of EC coverage by area of the lumen over time. Error bars represent the standard deviation (n = 12; ***: p < 0.001, one-way ANOVA).

Journal: bioRxiv

Article Title: Hierarchically Vascularized and Implantable Tissue Constructs created through Angiogenesis from Tissue-Engineered Vascular Grafts

doi: 10.1101/2024.04.29.591796

Figure Lengend Snippet: Endothelialization of the vascular grafts. a) A confocal image showing circumferential coverage of ECs on the lumen surface of the vascular graft after 7 days of culture, red: actin filaments stain (ActinRed™ 555), blue: nuclei stain (DAPI). b) Confocal images of ECs on the surface of the graft lumen at different time points showing the increase of endothelial coverage and proximity of the cells; scale bar = 50 μm. c) Quantitative analysis of EC coverage by area of the lumen over time. Error bars represent the standard deviation (n = 12; ***: p < 0.001, one-way ANOVA).

Article Snippet: Human umbilical vein ECs (Lonza, USA) and GFP expressing human umbilical vein ECs (Angio-Proteomie, USA) were cultured in EGM-2 medium (Lonza, USA) and endothelial growth medium ECs (Angio-Proteomie, USA), respectively, with 1% v/v antibiotic-antimycotic solution (Gibco, USA).

Techniques: Staining, Standard Deviation